L’outil de licence Creative Commons du formulaire de soumission ne fonctionne pas actuellement. Pour ajouter une licence CC à votre thèse ou publication, contactez ruor@uottawa.ca après le dépôt. -- The Creative Commons licence tool in the submission form is currently unavailable. To apply a CC licence to your thesis or publication, contact ruor@uottawa.ca after the deposit.

Relative abundance of a gut-derived Lancefieldella parvula strain is associated with severe inflammation in IBD

dc.contributor.authorWeerasingha, Sasanka
dc.contributor.authorYan, Austin
dc.contributor.authorButcher, James
dc.contributor.authorMack, David R.
dc.contributor.authorStintzi, Alain
dc.date.accessioned2026-11-17T04:30:52Z
dc.date.issued2026-08-14
dc.date.updated2026-11-17T04:30:53Z
dc.description.abstractAbstract Background Lancefieldella parvula (previously known as Atopobium parvulum) has been associated with inflammatory bowel disease (IBD); however, prior in vivo studies relied on an oral-derived reference strain rather than intestinal clinical isolates, limiting interpretation of its role in gut inflammation. To address this gap, we isolated a clinical strain of L. parvula (designated L. parvula TI19E08) from a mucosal luminal aspirate of an ulcerative colitis (UC) participant. We developed a strain-specific quantitative PCR assay to quantify its abundance across anatomical sites in treatment-naïve pediatric IBD participant (UC and Crohn’s disease (CD)) and examined its relationship with site-specific endoscopic inflammation severity. Results We demonstrated that the relative abundance of L. parvula TI19E08 increased with increasing local inflammation severity. In UC, both strain-specific and total L. parvula levels were strongly correlated with inflammation severity, particularly in the proximal colon. In CD patients, strain-level associations were most pronounced in the terminal ileum, which is consistent with the disease distribution. Conclusion This study characterizes an intestinal L. parvula isolate and demonstrates that strain-level expansion correlates with disease severity across IBD subtypes and anatomical regions. These findings identify L. parvula TI19E08 as a candidate mucosal marker of inflammation severity in IBD patients.
dc.identifier.citationGut Pathogens. 2026 Aug 14;18(1):84
dc.identifier.urihttps://doi.org/10.1186/s13099-026-00865-x
dc.identifier.urihttp://hdl.handle.net/10393/52235
dc.language.rfc3066en
dc.rights.holderThe Author(s)
dc.titleRelative abundance of a gut-derived Lancefieldella parvula strain is associated with severe inflammation in IBD
dc.typeJournal Article

Fichiers

Trousse originale

Voici les éléments 1 - 1 sur 1
En cours de chargement...
Vignette d'image
Nom:
13099_2026_Article_865.pdf
Taille:
2.21 MB
Format:
Adobe Portable Document Format

Trousse de licence

Voici les éléments 1 - 1 sur 1
En cours de chargement...
Vignette d'image
Nom:
license.txt
Taille:
2.51 KB
Format:
Item-specific license agreed upon to submission
Description: